Hypo-phosphataemia in children under five years with kwashiorkor and marasmic kwashiorkor

D Kimutai1, E Maleche-Obimbo, R Kamenwa

  • 1Ministry of Health, P O. Box 30016, Nairobi, Kenya.

Insights

Hypo-phosphataemia is prevalent in malnourished African children, worsening during initial re-feeding. Severe hypo-phosphataemia is linked to increased mortality in children with kwashiorkor and marasmic kwashiorkor.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Biochemistry

Background:

  • Severe malnutrition is a major cause of childhood mortality in developing nations.
  • Electrolyte depletion, particularly low phosphate, is common in malnourished children.
  • Refeeding can exacerbate electrolyte imbalances like hypo-phosphataemia, increasing risks.

Purpose of the Study:

  • To determine the prevalence of hypo-phosphataemia in children under five with kwashiorkor and marasmic kwashiorkor.
  • To evaluate the relationship between hypo-phosphataemia and nutritional intervention outcomes.
  • To assess the impact of hypo-phosphataemia on mortality in this population.

Main Methods:

  • A short longitudinal survey was conducted at Kenyatta National Hospital.
  • Children under five diagnosed with kwashiorkor or marasmic kwashiorkor were enrolled.
  • Serum phosphate levels and patient outcomes (survival/death) were monitored for five days.

Main Results:

  • 86% of admitted children had hypo-phosphataemia, peaking at 93% by day two.
  • Mean serum phosphate levels dropped significantly during the first two days of treatment.
  • A positive association was found between the severity of hypo-phosphataemia and mortality, with 21% mortality in severe cases.

Conclusions:

  • Hypo-phosphataemia is highly frequent in children with severe malnutrition presenting at KNH.
  • Serum phosphate levels critically decline in the initial days of nutritional support.
  • The severity of hypo-phosphataemia is a significant predictor of mortality in these vulnerable children.
Abstract

Related Concept Videos

Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...